ORTHOCIDE WG FUNGICIDE Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

orthocide wg fungicide

arysta lifescience north america llc - captan - water dispersible granule - captan carboximide active 800.0 g/kg - fungicide - apple | grape | ornamental seedling | pear | rose | stone fruit (see label for exceptions) | strawberry | tobacco seedling | tur - anthracnose on vines/rubus spp. | black spot - colletotrichum acutatum | black spot on apples | black spot on pears | black spot on rose - diplocarpon rosae | blossom blight - sclerotinia fructicola | blossom blight - sclerotinia laxa | brown patch - rhizoctonia solani | downy mildew on grape | gloeosporium fruit rot | grey mould - botrytis cinerea | leaf blight - phomopsis viticola | phomopsis cane | root rot - p. nicotianae var. parasitica | scorch | strawberry blight | wilt rootrot or damping off | anthracnose | apple scab | botrytis blight | botrytis rot | bunch rot | damping-off | leaf blight - d. obscurans | phomopsis cane | pythium root rot | pythium soil fungus | seedling root rot | soil fungi

Crystal-Skin White Plus Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

crystal-skin white plus

aus nature pharmaceuticals pty ltd - lycopersicon esculentum, quantity: 250 mg (equivalent: lycopersicon esculentum, qty 2.5 g; equivalent: steroidal alkaloids calculated as solanine, qty 0.025 mg); cysteine hydrochloride, quantity: 225 mg; rosa rugosa, quantity: 18.75 mg (equivalent: rosa rugosa, qty 187.5 mg); curcuma longa, quantity: 40 mg (equivalent: curcuma longa, qty 800 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; purified water; gelatin; titanium dioxide; amaranth; brilliant blue fcf; tartrazine - may assist in lightening skin at the production level. may assist in the reduction of melanin production. may help defend existing skin against uv damage. may help to defend newly produced skin with uv barriers. may promote collagen synthesis for a more youthful and full appearance. may assist in lightening age spots may assist in lightening freckles may assist in sun protection which in turn may assist with anti ageing and photo ageing. may assist with skin whitening, lightening and evening of skin tone. may protect and boost certain biomolecules.

MACRODANTIN- nitrofurantoin, macrocrystalline capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

macrodantin- nitrofurantoin, macrocrystalline capsule

procter & gamble pharmaceuticals - nitrofurantoin, macrocrystalline (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - capsule - 25 mg - macrodantin is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of macrodantin and other antibacterial drugs, macrodantin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. consequently, many patient

VITAFLO C SEED TREATMENT Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vitaflo c seed treatment

arysta lifescience australia pty ltd - carboxin; cypermethrin 45:55; ethylene glycol - suspension concentrates for seed treatment (fs) - carboxin carbamate-phenylcarbamate active 400.0 g/l; cypermethrin 45:55 pyrethroid active 3.2 g/l; ethylene glycol solvent other 96.9 g/l - mixed function seed treat - barley | oats | stored barley | stored oats | stored triticale | stored wheat grain | triticale | wheat - bunt | flag smut on cereal | granary weevil | indian meal moth | lesser grain borer | loose smut - ustilago tritici | rice weevil | rust-red flour beetle | sawtoothed grain beetle | smut - ustilago segetum var hordei | tropical warehouse moth | covered smut | grain borer | seedborne flag smut | soilborne flag smut | trilletia tritici

MACROBID- nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

macrobid- nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline capsule

procter and gamble pharmaceuticals, inc. - nitrofurantoin monohydrate (unii: e1qi2cqq1i) (nitrofurantoin - unii:927ah8112l), nitrofurantoin, macrocrystalline (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - capsule - macrobid is indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of escherichia coli or staphylococcus saprophyticus. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of macrobid and other antibacterial drugs, macrobid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. consequently, many patients who are treated with macrobid are predisposed to persisten

NITROFURANTOIN (MACROCRYSTALS)- nitrofurantoin (macrocrystals) capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nitrofurantoin (macrocrystals)- nitrofurantoin (macrocrystals) capsule

mylan pharmaceuticals inc. - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin 50 mg - nitrofurantoin macrocrystals capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus, and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin macrocrystals capsules and other antibacterial drugs, nitrofurantoin macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeut

NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS- nitrofurantoin monohydrate and nitrofurantoin macrocrystalline capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nitrofurantoin monohydrate/macrocrystals- nitrofurantoin monohydrate and nitrofurantoin macrocrystalline capsule

mylan institutional inc. - nitrofurantoin monohydrate (unii: e1qi2cqq1i) (nitrofurantoin - unii:927ah8112l), nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin 75 mg - nitrofurantoin capsules, usp (monohydrate/macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of escherichia coli or staphylococcus saprophyticus . nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules (monohydrate/macrocrystals)and other antibacterial drugs, nitrofurantoin capsules (monohydrate/macrocrystals)should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic age

NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS- nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nitrofurantoin monohydrate/macrocrystals- nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline capsule

physicians total care, inc. - nitrofurantoin monohydrate (unii: e1qi2cqq1i) (nitrofurantoin - unii:927ah8112l), nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin 75 mg - nitrofurantoin monohydrate/macrocrystals capsules are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of escherichia coli or staphylococcus saprophyticus . nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin monohydrate/macrocrystals capsules and other antibacterial drugs, nitrofurantoin monohydrate/macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic agents appro

NITROFURANTOIN (MACROCRYSTALS)- nitrofurantoin (macrocrystals) capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nitrofurantoin (macrocrystals)- nitrofurantoin (macrocrystals) capsule

lake erie medical & surgical supply dba quality care products llc - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin 100 mg - nitrofurantoin macrocrystals capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus, and certain susceptible strains of klebsiella, and enterobacter species. nitrofurantoin macrocrystals capsules are not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin macrocrystals capsules and other antibacterial drugs, nitrofurantoin macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distri

NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE- nitrofurantoin monohydrate/macrocrystalline capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nitrofurantoin monohydrate/ macrocrystalline- nitrofurantoin monohydrate/macrocrystalline capsule

st. mary's medical park pharmacy - nitrofurantoin monohydrate (unii: e1qi2cqq1i) (nitrofurantoin - unii:927ah8112l), nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin 25 mg - nitrofurantoin monohydrate/macrocrystals capsules are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of escherichia coli or staphylococcus saprophyticus . nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin monohydrate/macrocrystals capsules and other antibacterial drugs, nitrofurantoin monohydrate/macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic agents appro